Artwork

Content provided by MediCom Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MediCom Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The standard of care for patients receiving lenalidomide or thalidomide who are at high risk for VTE

3:36
 
Share
 

Manage episode 188136591 series 1375096
Content provided by MediCom Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MediCom Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. Ruben Niesvizky discusses clinical approaches to managing the risk of developing VTE in myeloma patients receiving immunomodulating agents such as lenalidomide or thalidomide.
  continue reading

53 episodes

Artwork
iconShare
 
Manage episode 188136591 series 1375096
Content provided by MediCom Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MediCom Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. Ruben Niesvizky discusses clinical approaches to managing the risk of developing VTE in myeloma patients receiving immunomodulating agents such as lenalidomide or thalidomide.
  continue reading

53 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide